@article{bb91efc1cbdf4dc6a4a5be875f51de14,
title = "Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase (PFKFB3)",
author = "Yoannis Imbert-Fernandez and Clem, \{Brian F.\} and Julie O'Neal and Kerr, \{Daniel A.\} and Robert Spaulding and Lilibeth Lanceta and Clem, \{Amy L.\} and Sucheta Telang and Jason Chesney",
note = "Chemicals E2, cycloheximide, and actinomycin D were purchased from Sigma-Aldrich. ICI 182,780 (Fulvestrant) was purchased from Tocris. PFK158 was provided by Advanced Cancer Therapeutics. The compound consists of ( E)-l-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-prop-2-en-l-one. Antibodies and Western Blotting Antibodies against PFKFB3 and β-actin were purchased from Proteintech and Sigma-Aldrich, respectively.",
year = "2014",
month = mar,
day = "28",
doi = "10.1074/JBC.M113.529990",
language = "American English",
volume = "289",
journal = "Journal of Biological Chemistry",
number = "13",
}